L501-0023 Screening compound: 1-{[4-(5-methyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-N-(pyridin-3-yl)piperidine-3-carboxamide

L501-0023 Screening compound: 1-{[4-(5-methyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-N-(pyridin-3-yl)piperidine-3-carboxamide
L501-0023 Screening compound: 1-{[4-(5-methyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-N-(pyridin-3-yl)piperidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L501-0023
1-{[4-(5-methyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-N-(pyridin-3-yl)piperidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L501-0023

Molecular Formula

C18H19N5O4S2 (C18 H19 N5 O4 S2)

Compound Name

1-{[4-(5-methyl-1,2,4-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-N-(pyridin-3-yl)piperidine-3-carboxamide

IUPAC name

1-{[4-(5-methyl-124-oxadiazol-3-yl)thiophen-2-yl]sulfonyl}-N-(pyridin-3-yl)piperidine-3-carboxamide

SMILES

Cc1nc(-c2csc(S(N(CCC3)CC3C(Nc3cnccc3)=O)(=O)=O)c2)no1

InChI

InChI=1S/C18H19N5O4S2/c1-12-20-17(22-27-12)14-8-16(28-11-14)29(25,26)23-7-3-4-13(10-23)18(24)21-15-5-2-6-19-9-15/h2,5-6,8-9,11,13H,3-4,7,10H2,1H3,(H,21,24)/t13-/m0/s1

InChI Key

VSUYBYRILOLZBH-ZDUSSCGKSA-N

MDL Number (MFCD)

MFCD27458637

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

433.51

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.597

Distribution Coefficient, logD

1.597

Water Solubility, LogSw

-1.94

Polar Surface Area

96.415

Acid Dissociation Constant (pKa)

11.04

Base Dissociation Constant (pKb)

3.88

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

33.30

L501-0023 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Targeted Diversity Library (40567 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
  • Others
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • Epigenetic
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with L501-0023 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L501-0023?
Check Price and Availability of L501-0023, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L501-0023 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L501-0023
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L501-0023
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L501-0023 available by request